Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

Discover the causes, symptoms, and treatment options for gout—a painful form of arthritis predominantly affecting men.

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Gout causes sudden flares of joint pain, which often arise during the nighttime, and in the big toe, though it may affect other joints including the ankles | Genetics And Genomics ...

A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are ...

Many types of medications, including over-the-counter (OTC) and prescription drugs, can help relieve joint pain due to ...

WALTHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of four abstracts that ...

The event, held on September 24th at the Mercury Drug Q-Plaza Branch in Cainta, Rizal, focused on the theme “Generics para sa ...

The use of SGLT2 inhibitors vs sulfonylurea was associated with a reduced risk for incident gout and MACE among patients with type 2 diabetes with/at risk for gout.

As Gout Gout's ascension in the world of athletics continues apace, the man responsible for guiding him to the top says he remains the same "happy-go-lucky" kid he has always been. Gout's manager ...

The venues, in Manchester and London, invite charity The Loop to test drugs behind the scenes ... at university to begin her degree. The use of crack cocaine increased by 594% in Ireland between ...

Sodium glucose cotransporter 2 inhibitors used to treat diabetes may also reduce the risk of recurrent kidney stones and gout ...